Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Intelligent Care Platform (ICP) Trial of Haibu Diabetes - A Quasi Experimental Type 2 Hybrid Implementation-Effectiveness Study

NCT07712809 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT07712809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07712809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Intelligent Care Platform (ICP) Trial of Haibu Diabetes - A Quasi Experimental Type 2 Hybrid Implementation-Effectiveness Study
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 15, 2026
Completion date
February 28, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes in children, diabetes type 1